Related Experiment Video
Updated: Apr 19, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Cardiorheumatology: cardiac involvement in systemic rheumatic disease
Megha Prasad1, Joerg Hermann1, Sherine E Gabriel2
1Division of Cardiovascular Disease, Department of Internal Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
Insights
Autoimmune rheumatic diseases significantly increase cardiovascular risks, including accelerated atherosclerosis, impacting heart health. Early detection and management of cardiac issues, alongside controlling inflammation and risk factors, are vital for patients.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Autoimmune rheumatic diseases present diverse cardiovascular manifestations affecting the heart and vasculature.
- These conditions elevate cardiovascular morbidity and mortality, with atherosclerosis being a major contributor, comparable to diabetes.
- Chronic inflammation from immune dysfunction exacerbates cardiovascular pathology beyond traditional risk factors.
Purpose of the Study:
- To review cardiovascular manifestations in rheumatological disorders.
- To explore the underlying pathophysiology of these cardiac complications.
- To discuss current and emerging management strategies, focusing on vascular aspects.
Main Methods:
- Comprehensive literature review of studies on autoimmune rheumatic diseases and cardiovascular complications.
- Analysis of pathophysiological mechanisms linking inflammation and cardiovascular disease.
- Synthesis of evidence on diagnostic and therapeutic approaches.
Main Results:
- Rheumatic diseases cause a wide spectrum of cardiac abnormalities, from silent conditions to severe outcomes.
- Accelerated, diffuse, and extensive coronary atherosclerosis is a significant concern in these patients.
- Inflammatory processes and immune dysregulation play a critical role in cardiovascular damage.
Conclusions:
- Prompt recognition and management of cardiovascular abnormalities are essential in patients with rheumatic diseases.
- Aggressive control of traditional cardiovascular risk factors is imperative.
- Therapeutic strategies targeting the underlying inflammatory process are crucial for reducing cardiovascular disease burden.
Abstract:
Autoimmune rheumatic diseases can affect the cardiac vasculature, valves, myocardium, pericardium, and conduction system, leading to a plethora of cardiovascular manifestations that can remain clinically silent or lead to substantial cardiovascular morbidity and mortality. Although the high risk of cardiovascular pathology in patients with autoimmune inflammatory rheumatological diseases is not owing to atherosclerosis alone, this particular condition contributes substantially to cardiovascular morbidity and mortality-the degree of coronary atherosclerosis observed in patients with rheumatic diseases can be as accelerated, diffuse, and extensive as in patients with diabetes mellitus. The high risk of atherosclerosis is not solely attributable to traditional cardiovascular risk factors: dysfunctional immune responses, a hallmark of patients with rheumatic disorders, are thought to cause chronic tissue-destructive inflammation. Prompt recognition of cardiovascular abnormalities is needed for timely and appropriate management, and aggressive control of traditional risk factors remains imperative in patients with rheumatic diseases. Moreover, therapies directed towards inflammatory process are crucial to reduce cardiovascular disease morbidity and mortality. In this Review, we examine the multiple cardiovascular manifestations in patients with rheumatological disorders, their underlying pathophysiology, and available management strategies, with particular emphasis on the vascular aspects of the emerging field of 'cardiorheumatology'.
More Related Videos
10:39Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy